Parkinson's Disease Trial, Recruiting NCT05767151 Sponsor: Xiangya Hospital of Central South University Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT05767151
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Parkinson's disease using standard medical diagnostic guidelines
  • Your Parkinson's diagnosis was made 2 years ago or less
  • Your Parkinson's symptoms are mild to moderate (at a level called Hoehn-Yahr stage 2 or below — confirm with trial site if unsure what stage you are)
  • You are between 30 and 75 years old
  • You have never taken any medication for Parkinson's disease
  • You are able to read and sign a consent form agreeing to take part in the trial

Who may not be able to join:

  • You have been diagnosed with a condition that looks similar to Parkinson's disease but is a different disorder (sometimes called "parkinsonism")
  • You are already taking any medication for Parkinson's disease
  • You have been found to have problems with memory or thinking (cognitive impairment)
  • You are unable to read or sign a consent form agreeing to take part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8613974936815

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Xiangya Hospital of Central South University
Registry
ClinicalTrials.gov
Start date
1 January 2021
Est. completion
1 January 2031

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The Unified Parkinson's Disease Rating Scale for evaluating motor subtypes; The clinical stage of PD is assessed by Hoehn and Yahr scale; The non-motor symptoms are evaluated by Non-motor Symptom Scale; Constipation was diagnosed by Functional Constipation Diagnostic Criteria Rome III; The PDQ-39 was used to assess the quality of life; Sleep quality is evaluated by Parkinson's Disease Sleep Scale; Epworth Sleepiness Scale evaluates excessive sleepiness; Probable rapid eye movement sleep behavior disorder was diagnosed by Probable rapid eye movement sleep behavior disorder Questionnaire -Hongko...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov